[Distribution characteristics of serum HBsAg levels in Chinese patients with chronic hepatitis B based on CR-HepB]. [PDF]
Chen SY +12 more
europepmc +1 more source
[Dynamic changes of HBsAb and its predictive value in patients with chronic hepatitis B receiving antiviral therapy for clinical cure]. [PDF]
Yang HY +10 more
europepmc +1 more source
[A case of chronic hepatitis B patient with sequential treatment of tenofovir and pegylated interferon alpha]. [PDF]
Huang Z, Wang YP, Li JP.
europepmc +1 more source
[Research progress on novel antiviral therapeutic drugs for chronic hepatitis B]. [PDF]
Cai N, Hu P.
europepmc +2 more sources
[Application value of an aMAP score in predicting the occurrence of hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy]. [PDF]
Gao YF, Liu ZZ, Ma LY, Liu YX, Zhao CY.
europepmc +1 more source
[A case of chronic hepatitis B who achieved clinical cure with pegylated interferon alfa intermittent and combination therapy]. [PDF]
Wang SY, Deng W, Li MH.
europepmc +1 more source
[Effects of PEG-IFN-α treatment on the expression of CD<sup>+</sup>161 and PD-1 in CD8<sup>+</sup> T cells of patients with chronic hepatitis B]. [PDF]
Li YP +6 more
europepmc +1 more source
[Research progress on the impact of metabolic associated fatty liver disease on viral activity, treatment response, and prognosis in patients with chronic hepatitis B: current status and prospects]. [PDF]
Gong H, Zhao TT, Huang M, Liu CC, He N.
europepmc +1 more source
[Clinical efficacy of switching to tenofovir amibufenamide tablets with poor response to entecavir in patients with chronic hepatitis B]. [PDF]
Li Y, Wang WY.
europepmc +1 more source

